John T. Henderson, Director at MYRIAD GENETICS INC (MYGN), sold 40,000 shares at $27.60 ($1.1M) on 2012-12-10, disclosed to the SEC on 2012-12-11.
Open-market sale of $1.1M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.60 | 10,000 | $276K | 24.9% |
| 2 | $27.60 | 11,254 | $311K | 28.1% |
| 3 | $27.72 | 18,746 | $520K | 47.0% |
| Total | $27.66 avg | 40,000 | $1.1M | 100% |
| Filing → |
| CYTK | SELL | 2025-04-16 | $247K | — | Filing → |
| CYTK | SELL | 2024-12-12 | $179K | — | Filing → |
| CYTK | SELL | 2024-04-25 | $1.4M | — | Filing → |